Catalunya Ràdio, El Punt Avui, Expansión Catalunya, Europa Press, EFE, among other media, have published an article about the launch of the #MetastasisChallenge campaign. Through this initiative, the Institute for Research in Biomedicine (IRB Barcelona) calls society to action to support research into metastasis—the main cause of death from cancer—by raising €5 M over the next four years.
Link to El Punt Avui
Through the campaign called #MetastasisChallenge, the centre aims to raise €5 M over the next four years.
Metastasis is responsible for 90% of deaths from cancer, and this campaign aims to rally social support for research in order to speed up discoveries.
Betevé Notícies Vespre has interviewed Eduard Batlle, coordinator to the Cancer Programme at the Institute for Research in Biomedicine (IRB Barcelona), about the recent campaign launched by the centre to raise funds for research into metastasis. “We have been studying metastasis at the centre for 10-12 years and have made some important findings. We now feel that it is a timely to push advances in this research, and with greater resources we will be able to speed up the process,” said Eduard Batlle.
Awards for outstanding creation, research and production developed in Barcelona
The Barcelona City Council acknowledges the impact of his studies in cancer and metastasis
The announcement made yesterday by the Chinese scientist He Jiankui that twins Lulu and Nana had been born after editing their DNA has brought about a storm of criticisms and generated alarm among the scientific community and society. (*Chinese researcher claims first gene-edited babies. Associated Press). The gene editing of embryos may become (or not) a reality in the future, but right now it is clearly premature.
The Chinese researcher He Jiankui has crossed all the red lines because before...
The projects address breast, lung, colon, prostate and melanoma cancer.
El Punt Avui and La Vanguardia have published an article about the European Research Council (ERC) Proof of Concept grants. Five of them were given to centres belonging to the Barcelona Institute of Science and Technology (BIST), two corresponding to researchers Eduard Batlle and Angel R. Nebreda at IRB Barcelona.
Link to La Vanguardia: España, líder en la última convocatoria de ciencia europea (in Spanish)
Link to El Punt Avui:...
IRB Barcelona has been awarded two ERC PoC grants to optimise and validate tools with potential clinical applications.
Angel R. Nebreda’s project seeks to develop treatments to reduce the cardiotoxicity caused by chemotherapy.
Eduard Batlle’s project will build a biobank of mouse tumour organoids with the aim to contribute to the treatment of patients with advanced colon cancer.
Immunotherapy is gaining ground in the fight against cancer. The tumour has a strategy to evade detection by the immune system, thus allowing it to spread throughout the body. Science has discovered this therapy and is working on overcoming this evasion strategy. In this regard, La República has published an interview with Eduard Batlle, head of the Colorectal Cancer Lab at IRB Barcelona.
The Heraldo newspaper has published an article about the role of immunotherapy to rearm patients’ defences and contribute to the fight against cancer. In the article, the authors mention the work of Eduard Batlle, ICREA researcher at IRB Barcelona, on the effectiveness that enhances immune system function in colon cancer.
Link to Heraldo